Bob has spent over twenty years building, leading and motivating program and alliance management teams to support clinical programs from early development to late stage clinical trials.
Prior to ElevateBio, Bob was the Director of Program and Alliance Management at Alnylam Pharmaceuticals and the Program Lead for an HBV-targeting siRNA drug candidate in a partnered program. Previous to Alnylam, Bob was the Sr. Director of Immunotherapy and Alliance Management at the Fred Hutchinson Cancer Research Center, leading the clinical operations and cellular manufacturing teams and managing business partnerships with Juno Therapeutics and Nohla Therapeutics. Bob established the alliance management function at Fred Hutch and has held program and alliance management leadership positions with IDRI, Idera Pharmaceuticals, Omeros Corporation, and Praecis Pharmaceuticals.
Education & Accomplishments
Bob holds a PhD in cardiovascular physiology from Dartmouth College and BA in biochemistry and classics from Bowdoin College.
Interested in working with people like Bob? We’re looking for pioneers and innovative thinkers committed to developing the next-generation of cell and gene therapies. Review our open roles and find your future.